Simple Science

Cutting edge science explained simply

# Biology # Biochemistry

Unlocking the Secrets of SMYD2: A Key Player in Cancer

Discover how SMYD2 influences protein function and its role in cancer therapy.

Yingxue Zhang, Eid Alshammari, Jacob Sobota, Nicolas Spellmon, Emerson Perry, Tianxin Cao, Thamarahansi Mugunamalwaththa, Sheila Smith, Joseph Brunzelle, Gensheng Wu, Timothy Stemmler, Jianping Jin, Chunying Li, Zhe Yang

― 5 min read


SMYD2: Cancer's Hidden SMYD2: Cancer's Hidden Weapon and potential therapies. Uncover SMYD2's crucial role in cancer
Table of Contents

SMYD2 is a special protein that belongs to a family called lysine methyltransferases. These proteins play a big role in modifying other proteins by adding a tiny chemical group called a methyl group to specific spots on the protein. Think of it as giving a protein a little "pep talk" to boost its performance. SMYD2 is involved in various important processes in the cell, such as controlling gene activity, responding to stress, and managing the cell cycle, which is the process of how a cell grows and divides.

The Magical Allosteric Site

Now, here comes the exciting part! SMYD2 has a special location on its structure known as an allosteric site. This site is like a secret door that can change how the rest of the protein behaves. Normally, proteins have specific spots (Active Sites) where they do their work. The allosteric site doesn't do the main job directly but influences how well the active site works, almost like a cheerleader boosting the team's morale from the sidelines.

Why is Allosteric Regulation Important?

Think of allosteric regulation as a clever trick that cells use to adjust their activities quickly in response to changing conditions. For example, if a cell needs to move fast to deal with a stressful situation, it can use allosteric regulation to speed up reactions that are essential for survival. It's like an orchestra conductor who can change the tempo of a performance based on how the music unfolds.

The Discovery of the Allosteric Site in SMYD2

Researchers recently found that SMYD2 has a highly flexible allosteric site that can bind different molecules, which is quite impressive! This flexibility allows the protein to interact with a variety of partners, including small molecules, peptides, and even proteins. It's like SMYD2 has many friends in different circles, ready to party at a moment's notice.

How Does the Allosteric Site Work?

The allosteric site can bind to something first, which then helps the active site get busy with its work. When the allosteric site has a visitor (a molecule), the structure of SMYD2 changes just enough to make the active site more effective. This is also known as positive cooperativity. Imagine you're at a basketball game, and every time your favorite player scores a basket, it brings the whole team together to play better. That's what happens here!

The Structure of SMYD2

When scientists looked closely at SMYD2 using a technique called X-ray crystallography, they revealed its three-dimensional shape. SMYD2 has a complex structure made up of different parts, including the SET domain. This domain is where the magic of adding methyl groups happens. The new allosteric site is located near the substrate binding site, which is where proteins or peptides get modified.

The Secret Life of the Allosteric Site

The allosteric site has been shown to be quite the social butterfly. It has been observed to bind various partners, including a polymer called polyethylene glycol (PEG) and even small molecules like glycerol. Researchers were surprised to see how adaptable this site could be. It's like the allosteric site has a wardrobe full of outfits to wear, depending on the occasion.

How Does Mutation Affect SMYD2?

Scientists decided to take a closer look at what happens when they introduce specific Mutations in SMYD2. They created mutant versions of the protein to see how it impacts its function. Some mutants disrupted the allosteric site, which ended up affecting how well the active site could bind its target. It was like removing a key player from the team and watching the performance drop dramatically.

A Closer Look at Binding

Next, the researchers examined how SMYD2 interacts with a peptide called PARP1. They used a method called isothermal titration calorimetry (ITC) to study the binding dynamics. ITC revealed that wild-type SMYD2 binds two peptide molecules, while one specific mutant only binds one. This suggests that having a well-functioning allosteric site is crucial for the smooth operational flow of the entire protein.

The Role of SMYD2 in Cancer

Now that we know about the allosteric site, we should mention that SMYD2 has a significant role in the world of cancer. Research has shown that SMYD2 is often overexpressed in various types of cancer, leading to worse outcomes for patients. This means there's a lot of interest in designing drugs that can target SMYD2 specifically, which could help in the fight against cancer.

Drug Development Opportunities

Targeting the allosteric site for drug design means fewer side effects and more specificity compared to hitting the active site directly. Remember how we discussed how active sites are often similar between proteins? Allosteric Sites tend to be less conserved, making them excellent targets for drug discovery. It's like finding a secret passageway in a house that lets you get to the treasure without tripping over the laser traps in the main hall.

The Future of Research on SMYD2

Given that our understanding of SMYD2 is still evolving, there's a lot more to explore regarding how it fits into cellular functions and disease mechanisms. Researchers are also excited about understanding how the regulation of SMYD2 can be fine-tuned in response to various signals. There are many unanswered questions, which means scientists will be busy trying to decode the details of SMYD2's functions and interactions for years to come.

Conclusion

In summary, SMYD2 is a fascinating protein that plays a key role in modifying other proteins. The discovery of its allosteric site provides insights into how this protein functions and opens exciting possibilities for therapeutic interventions, especially in cancer treatment. Who knew a little protein could have such a big impact? It’s like finding out that your unassuming neighbor is actually a superhero in disguise! As researchers continue to dive deeper into the workings of SMYD2, we can expect more incredible discoveries that could lead to better treatments for various diseases.

Original Source

Title: Structure of the SMYD2-PARP1 Complex Reveals Both Productive and Allosteric Modes of Peptide Binding

Abstract: Allosteric regulation allows proteins to dynamically respond to environmental cues by modulating activity at sites away from the catalytic center. Despite its importance, the SET-domain protein lysine methyltransferase superfamily has been understudied. Here, we present four crystal structures of SMYD2, a unique family member with a MYND domain. Our findings reveal a novel allosteric binding site with high conformational plasticity and promiscuity, capable of binding peptides, proteins, PEG, and small molecules. This site exhibits positive cooperativity with substrate binding, influencing catalytic activity. Mutations here significantly alter substrate affinity, changing the enzymes kinetic profile. Specificity studies show interaction with PARP1 but not histones, suggesting targeted regulation. Interestingly, this sites function remains unaffected by active site changes, indicating unidirectional mechanisms. Our discovery provides novel insights into SMYD2s biochemical regulation and lays the foundation for broader research on allosteric control in lysine methyltransferases. Given SMYD2s role in various cancers, this work opens exciting avenues for designing specific allosteric inhibitors with reduced off-target effects.

Authors: Yingxue Zhang, Eid Alshammari, Jacob Sobota, Nicolas Spellmon, Emerson Perry, Tianxin Cao, Thamarahansi Mugunamalwaththa, Sheila Smith, Joseph Brunzelle, Gensheng Wu, Timothy Stemmler, Jianping Jin, Chunying Li, Zhe Yang

Last Update: 2024-12-04 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.03.626679

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.03.626679.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles